Global Cancer Biomarkers Market

Market Overview:

The global Cancer Biomarkers Marketwas valued at USD 10.19 billion in 2016 and is projected to reach USD 28.03billion by 2025, growing at a CAGR of 11.9% from 2017 to 2025.
Cancer Biomarkers have high usage in Cancer diagnostics and treatment, especially in Tissue specific therapies. Therefore market of this genetically engineered product is seeing high values in terms of market value.

Sample Infographics:




Market Dynamics:
1. Market Drivers
1.1 Increasing Technological Developments
1.2 Growingnumber of cancer Patients and usage of biomarkers
1.3 Increasing research in biomarkers
2. Market Restraints
2.1 Reimbursements Risks
2.2 High investment and uncertainty of favorable profits
2.3 Technicality concerns

Market Segmentation:
1. Global Cancer Biomarkers Market, by Application:
1.1 Diagnostics
1.2 Research and Development
1.3 Prognostics
1.4 Risk Assessment
1.5 Other Applications

2. Global Cancer Biomarkers Market, by Cancer Type:
2.1 Breast Cancer
2.2 Lung Cancer
2.3 Colorectal Cancer
2.4 Prostate Cancer
2.5 Non-Hodgkin’s Lymphoma
2.6 Melanoma
2.7 Leukemia
2.8 Thyroid Cancer
2.9 Bladder Cancer
2.10 Kidney Cance
2.11 Other Cancer Types

3. Global Cancer Biomarkers Market, by Profiling Technology:
3.1 Omics Technologies
3.1.1 Proteomics
3.1.2 Genomics
3.1.2.1 Next-Generation Sequencing (NGS)
3.1.2.2 Polymerase Chain Reaction (PCR)
3.1.3 Other Omics Technologies
3.2 Imaging Technologies
3.2.1 Ultrasound
3.2.2 Computed Tomography (Ct)
3.2.3 Magnetic Resonance Imaging (Mri)
3.2.4 Positron Emission Tomography (Pet)
3.2.5 Mammography
3.3 Immunoassays
3.4 Cytogenetics
3.4.1 in Situ Hybridization (Ish)
3.4.2 Other Cytogenetics-Based Tests
3.5 Bioinformatics

4. Global Cancer Biomarkers Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific
2. Bio-Rad Laboratories
3. Roche Diagnostics
4. Qiagen N.V.
5. Illumina
6. GE Healthcare
7. Agilent Technologies
8. Biomérieux SA
9. Merck & Co.
10. Abbott Laboratories
11. Becton, Dickinson and Company
12. Danaher Corporation
13. Myriad Genetics
14. Sysmex Corporation
15. Hologic
16. Quest Diagnostics

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cancer Biomarkers Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL CANCER BIOMARKERS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CANCER BIOMARKERS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION
5.1 Diagnostics
5.2 Research and Development
5.3 Prognostics
5.4 Risk Assessment
5.5 Other Applications

6 GLOBAL CANCER BIOMARKERS MARKET, BY CANCER TYPE
6.1 Breast Cancer
6.2 Lung Cancer
6.3 Colorectal Cancer
6.4 Prostate Cancer
6.5 Non-Hodgkin’s Lymphoma
6.6 Melanoma
6.7 Leukemia
6.8 Thyroid Cancer
6.9 Bladder Cancer
6.10 Kidney Cancer
6.11 Other Cancer Types

7 GLOBAL CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY
7.1 Omics Technologies
7.1.1 Proteomics
7.1.2 Genomics
7.1.3 Other Omics Technologies

7.2 Imaging Technologies
7.2.1 Ultrasound
7.2.2 Computed Tomography (Ct)
7.2.3 Magnetic Resonance Imaging (Mri)
7.2.4 Positron Emission Tomography (Pet)
7.2.5 Mammography

7.3 Immunoassays

7.4 Cytogenetics
7.4.1 in Situ Hybridization (Ish)
7.4.2 Other Cytogenetics-Based Tests
7.5 Bioinformatics

8 GLOBAL CANCER BIOMARKERS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

9 GLOBAL CANCER BIOMARKERS MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Thermo Fisher Scientific
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Bio-Rad Laboratories
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Roche Diagnostics
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Qiagen N.V.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Illumina
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 GE Healthcare
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Agilent Technologies
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Biomérieux SA
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Merck & Co.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Abbott Laboratories
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Becton, Dickinson and Company
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 Danaher Corporation
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

10.13 Myriad Genetics
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments

10.14 Sysmex Corporation
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments

10.15 Hologic
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Developments

11 Appendix
11.1 Related Reports

Global Cervical Cancer Diagnostic Tests Market Research Report 2019-2023

Published Date : Nov 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Cervical Cancer Diagnostic Tests Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world...

Global Hypopharyngeal Cancer Treatment Market Research Report 2019-2023

Published Date : Nov 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Hypopharyngeal Cancer Treatment Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world'...

Global Blood Cancer Drugs Market Research Report 2019-2027

Published Date : Sep 2019

Blood cancers, or hematologic cancers, affect the production and function of blood cells. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Blood Cancer Drugs Report by Material, Application, and Geography - Global Forec...

Pancreatic And Bile Duct Cancer Drugs Market

Published Date : Aug 2019

What are Pancreatic and Bile Duct Cancer Drugs? Pancreatic and bile duct cancer drugs are of different types. Some treat cancer while others help to relieve symptoms such as sickness and pain. 5-fluorouracil, gemcitabine, cisplatin, capecitabine, oxaliplatin have commonly used drugs for bile d...

Global Duodenal Cancer Market Research Report 2019-2027

Published Date : Aug 2019

Duodenal cancer is a cancer in the first section of the small intestine known as the duodenum. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Duodenal Cancer Report by Material, Application, and Geography - Global For...

Global Ovarian Cancer Market Research Report 2019-2027

Published Date : Aug 2019

Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer incidence and mortality worldwide. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Ovarian Cancer Report by Material, Applicati...

Global Anti-Cancer Drugs Market Research Report 2019-2027

Published Date : Jul 2019

Anti-Cancer Drugs includes Traditional Chinese Medicine and Western Medicine on the base of classification. Cancer Treatment is the main application of Anti-Cancer Drugs product and North American is the largest Anti-Cancer Drugs market on production and consumption. Globa...

Global Cancer Treatment Drugs Market Research Report 2019-2027

Published Date : Jul 2019

Cancer treatment is the use of surgery, radiation, medications and other therapies to cure a cancer, shrink a cancer or stop the progression of a cancer. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Cancer Treatment...

Global Pituitary Cancer Market Research Report 2019-2027

Published Date : Jul 2019

A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Pituitary Cancer Report by Material, and Geography - Global Forecast to 2023 is...

Global Ocular Cancer Drug Market Research Report 2019-2027

Published Date : Jul 2019

Ocular Cancer Drug refers to a drug specifically for the treatment of Ocular Cancer. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Ocular Cancer Drug Report by Material, Application, and Geography - Global Forecast t...

 

Select License :

  • Single User : $3950
  • Multiple User : $4750
  • Corporate User : $6750

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.